{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:53:40Z","timestamp":1793393620528,"version":"4.5.0"},"reference-count":30,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,5,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>TET2 and DNMT3A mutations are frequently identified in T-cell lymphomas of T follicular helper cell origin (TCL-TFH), clonal hematopoiesis (CH), and myeloid neoplasms (MNs). The relationships among these 3 entities, however, are not well understood. We performed comprehensive genomic studies on paired bone marrow and tissue samples as well as on flow cytometry\u2013sorted bone marrow and peripheral blood subpopulations from a cohort of 22 patients with TCL-TFH to identify shared CH-type mutations in various hematopoietic cell compartments. Identical mutations were detected in the neoplastic T-cell and myeloid compartments of 15 out of 22 patients (68%), including TET2 (14\/15) and DNMT3A (10\/15). Four patients developed MNs, all of which shared CH-type mutations with their TCL-TFH; additional unique genetic alterations were also detected in each patient\u2019s TCL-TFH and MN. These data demonstrate that CH is prevalent in patients with TCL-TFH and that divergent evolution of a CH clone may give rise to both TCL-TFH and MNs.<\/jats:p>","DOI":"10.1182\/bloodadvances.2020001636","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T11:30:45Z","timestamp":1590147045000},"page":"2261-2271","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":114,"title":["Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms"],"prefix":"10.1182","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0640-7114","authenticated-orcid":false,"given":"Natasha E.","family":"Lewis","sequence":"first","affiliation":[{"name":"Hematopathology Service, Department of Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4048-8376","authenticated-orcid":false,"given":"Kseniya","family":"Petrova-Drus","sequence":"first","affiliation":[{"name":"Hematopathology Service, Department of Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Huet","sequence":"first","affiliation":[{"name":"Hematopathology Service, Department of Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary D.","family":"Epstein-Peterson","sequence":"first","affiliation":[{"name":"Lymphoma Service, Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Gao","sequence":"first","affiliation":[{"name":"Hematopathology Service, Department of Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison E.","family":"Sigler","sequence":"first","affiliation":[{"name":"Hematopathology Service, Department of Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeeyeon","family":"Baik","sequence":"first","affiliation":[{"name":"Hematopathology Service, Department of Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neval","family":"Ozkaya","sequence":"first","affiliation":[{"name":"Hematopathology Service, Department of Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison J.","family":"Moskowitz","sequence":"first","affiliation":[{"name":"Lymphoma Service, Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Kumar","sequence":"first","affiliation":[{"name":"Lymphoma Service, Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Horwitz","sequence":"first","affiliation":[{"name":"Lymphoma Service, Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanming","family":"Zhang","sequence":"first","affiliation":[{"name":"Cytogenetic Laboratory, Department of Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Arcila","sequence":"first","affiliation":[{"name":"Molecular Diagnostic Laboratory, Department of Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross L.","family":"Levine","sequence":"first","affiliation":[{"name":"Molecular Cancer Medicine Service, Human Oncology and Pathogenesis Program,"},{"name":"Leukemia Service, Department of Medicine, and"},{"name":"Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Roshal","sequence":"first","affiliation":[{"name":"Hematopathology Service, Department of Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6576-5256","authenticated-orcid":false,"given":"Ahmet","family":"Dogan","sequence":"first","affiliation":[{"name":"Hematopathology Service, Department of Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8586-8500","authenticated-orcid":false,"given":"Wenbin","family":"Xiao","sequence":"first","affiliation":[{"name":"Hematopathology Service, Department of Pathology,"},{"name":"Molecular Cancer Medicine Service, Human Oncology and Pathogenesis Program,"},{"name":"Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,5,22]]},"reference":[{"issue":"3","key":"2020052211303751000_B1","doi-asserted-by":"crossref","first-page":"e92585","DOI":"10.1371\/journal.pone.0092585","article-title":"No survival improvement for patients with angioimmunoblastic T-cell lymphoma over the past two decades: a population-based study of 1207 cases","volume":"9","author":"Xu","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"2020052211303751000_B2","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2011-11-391748","article-title":"IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma","volume":"119","author":"Cairns","year":"2012","journal-title":"Blood"},{"issue":"1","key":"2020052211303751000_B3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJMc1111708","article-title":"TET2 and DNMT3A mutations in human T-cell lymphoma","volume":"366","author":"Couronn\u00e9","year":"2012","journal-title":"N Engl J Med"},{"issue":"7","key":"2020052211303751000_B4","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","article-title":"Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters","volume":"120","author":"Lemonnier","year":"2012","journal-title":"Blood"},{"issue":"9","key":"2020052211303751000_B5","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","article-title":"A targeted mutational landscape of angioimmunoblastic T-cell lymphoma","volume":"123","author":"Odejide","year":"2014","journal-title":"Blood"},{"issue":"2","key":"2020052211303751000_B6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas","volume":"46","author":"Palomero","year":"2014","journal-title":"Nat Genet"},{"issue":"1","key":"2020052211303751000_B7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","article-title":"TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis","volume":"20","author":"Quivoron","year":"2011","journal-title":"Cancer Cell"},{"issue":"2","key":"2020052211303751000_B8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat Genet"},{"issue":"15","key":"2020052211303751000_B9","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood-2015-05-644591","article-title":"IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma","volume":"126","author":"Wang","year":"2015","journal-title":"Blood"},{"issue":"4","key":"2020052211303751000_B10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ng.2916","article-title":"A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma","volume":"46","author":"Yoo","year":"2014","journal-title":"Nat Genet"},{"issue":"26","key":"2020052211303751000_B11","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"issue":"26","key":"2020052211303751000_B12","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"issue":"12","key":"2020052211303751000_B13","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies","volume":"20","author":"Xie","year":"2014","journal-title":"Nat Med"},{"issue":"11","key":"2020052211303751000_B14","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/ng.2413","article-title":"Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis","volume":"44","author":"Busque","year":"2012","journal-title":"Nat Genet"},{"issue":"1","key":"2020052211303751000_B15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1182\/blood-2009-03-210039","article-title":"Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies","volume":"114","author":"Abdel-Wahab","year":"2009","journal-title":"Blood"},{"issue":"25","key":"2020052211303751000_B16","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1056\/NEJMoa1005143","article-title":"DNMT3A mutations in acute myeloid leukemia","volume":"363","author":"Ley","year":"2010","journal-title":"N Engl J Med"},{"issue":"22","key":"2020052211303751000_B17","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","article-title":"Clinical and biological implications of driver mutations in myelodysplastic syndromes","volume":"122","author":"Papaemmanuil","year":"2013","journal-title":"Blood"},{"issue":"6","key":"2020052211303751000_B18","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/bjh.13170","article-title":"Efficacy of 5-azacytidine in a TET2 mutated angioimmunoblastic T cell lymphoma","volume":"168","author":"Cheminant","year":"2015","journal-title":"Br J Haematol"},{"issue":"10","key":"2020052211303751000_B19","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMc1806413","article-title":"High-risk clonal hematopoiesis as the origin of AITL and NPM1-mutated AML","volume":"379","author":"Tiacci","year":"2018","journal-title":"N Engl J Med"},{"issue":"13","key":"2020052211303751000_B20","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1080\/10428194.2019.1627541","article-title":"Angioimmunoblastic T-cell lymphoma and myelodysplastic syndrome with mutations in TET2, DNMT3 and CUX1 - azacitidine induces only lymphoma remission","volume":"60","author":"Tobiasson","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"2020052211303751000_B21","doi-asserted-by":"crossref","first-page":"E427","DOI":"10.3390\/biom9090427","article-title":"Function, regulation and biological roles of PI3K\u03b3 variants","volume":"9","author":"N\u00fcrnberg","year":"2019","journal-title":"Biomolecules"},{"key":"2020052211303751000_B22","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the Catalogue Of Somatic Mutations In Cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2020052211303751000_B23","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1086\/426403","article-title":"CHEK2 is a multiorgan cancer susceptibility gene","volume":"75","author":"Cybulski","year":"2004","journal-title":"Am J Hum Genet"},{"issue":"6","key":"2020052211303751000_B24","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1182\/blood-2017-04-777029","article-title":"DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions","volume":"130","author":"Buscarlet","year":"2017","journal-title":"Blood"},{"issue":"1","key":"2020052211303751000_B25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ajhg.2017.05.013","article-title":"Ultra-sensitive sequencing identifies high prevalence of clonal hematopoiesis-associated mutations throughout adult life","volume":"101","author":"Acuna-Hidalgo","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"14","key":"2020052211303751000_B26","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1200\/JCO.2016.71.6712","article-title":"Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma","volume":"35","author":"Gibson","year":"2017","journal-title":"J Clin Oncol"},{"issue":"2","key":"2020052211303751000_B27","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/bjh.15451","article-title":"A population-based analysis of second primary malignancies in T-cell neoplasms","volume":"185","author":"Kommalapati","year":"2019","journal-title":"Br J Haematol"},{"key":"2020052211303751000_B28","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017","edition":"Revised 4th ed"},{"key":"2020052211303751000_B29","doi-asserted-by":"crossref","first-page":"haematol.2019.225839","DOI":"10.3324\/haematol.2019.225839","article-title":"Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohort","author":"Holst","year":"2019","journal-title":"Haematologica"},{"issue":"4","key":"2020052211303751000_B30","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/hon.2319","article-title":"Response to 5-azacytidine in a patient with TET2-mutated angioimmunoblastic T-cell lymphoma and chronic myelomonocytic leukaemia preceded by an EBV-positive large B-cell lymphoma","volume":"35","author":"Saillard","year":"2017","journal-title":"Hematol Oncol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/10\/2261\/1731811\/advancesadv2020001636.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/10\/2261\/1731811\/advancesadv2020001636.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T11:31:09Z","timestamp":1590147069000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/10\/2261\/456037\/Clonal-hematopoiesis-in-angioimmunoblastic-Tcell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,22]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,5,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2020001636","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,22]]}}}